But Washington companies didn't attract as much cash as in the recent past, as new funding for local biotech plummeted. An Ernst & Young/VentureOne report ranked the state in eighth place by dollar amount received, down from third in the second quarter.
By Ángel González
Seattle Times business reporter
Full Story: http://seattletimes.nwsource.com/html/businesstechnology/2003963284_venturecapital20.html